1. Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
- Author
-
Luczak, Elizabeth D, Wu, Yuejin, Granger, Jonathan M, Joiner, Mei-Ling A, Wilson, Nicholas R, Gupta, Ashish, Umapathi, Priya, Murphy, Kevin R, Reyes Gaido, Oscar E, Sabet, Amin, Corradini, Eleonora, Tseng, Wen-Wei, Wang, Yibin, Heck, Albert J R, Wei, An-Chi, Weiss, Robert G, Anderson, Mark E, Sub Biomol.Mass Spectrometry & Proteom., Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics, Sub Biomol.Mass Spectrometry & Proteom., Afd Biomol.Mass Spect. and Proteomics, and Biomolecular Mass Spectrometry and Proteomics
- Subjects
0301 basic medicine ,Heart Failure/metabolism ,Cardiomyopathy ,Myocardial Infarction ,General Physics and Astronomy ,02 engineering and technology ,Mitochondrion ,Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ,Cardiovascular ,Transgenic ,Mice ,Dilated ,2.1 Biological and endogenous factors ,Myocardial infarction ,Aetiology ,lcsh:Science ,Multidisciplinary ,Dilated cardiomyopathy ,021001 nanoscience & nanotechnology ,Dilated/metabolism ,Heart Disease ,Mitochondrial Proteins/genetics ,cardiovascular system ,Signal transduction ,0210 nano-technology ,Signal Transduction ,Cardiomyopathy, Dilated ,medicine.medical_specialty ,Calcium/metabolism ,Science ,Heart Ventricles ,Diastole ,Mice, Transgenic ,General Biochemistry, Genetics and Molecular Biology ,Article ,Mitochondrial Proteins ,Heart Ventricles/physiopathology ,03 medical and health sciences ,Calcium-Binding Proteins/metabolism ,Ca2+/calmodulin-dependent protein kinase ,Internal medicine ,medicine ,Animals ,Cardiomyopathy, Dilated/metabolism ,Heart Disease - Coronary Heart Disease ,Heart Failure ,Energy Metabolism/genetics ,business.industry ,Myocardial Infarction/physiopathology ,Calcium-Binding Proteins ,General Chemistry ,Energy metabolism ,medicine.disease ,030104 developmental biology ,Endocrinology ,Heart failure ,lcsh:Q ,Calcium ,business ,Energy Metabolism ,Calcium-Calmodulin-Dependent Protein Kinase Type 2 - Abstract
Despite the clear association between myocardial injury, heart failure and depressed myocardial energetics, little is known about upstream signals responsible for remodeling myocardial metabolism after pathological stress. Here, we report increased mitochondrial calmodulin kinase II (CaMKII) activation and left ventricular dilation in mice one week after myocardial infarction (MI) surgery. By contrast, mice with genetic mitochondrial CaMKII inhibition are protected from left ventricular dilation and dysfunction after MI. Mice with myocardial and mitochondrial CaMKII overexpression (mtCaMKII) have severe dilated cardiomyopathy and decreased ATP that causes elevated cytoplasmic resting (diastolic) Ca2+ concentration and reduced mechanical performance. We map a metabolic pathway that rescues disease phenotypes in mtCaMKII mice, providing insights into physiological and pathological metabolic consequences of CaMKII signaling in mitochondria. Our findings suggest myocardial dilation, a disease phenotype lacking specific therapies, can be prevented by targeted replacement of mitochondrial creatine kinase or mitochondrial-targeted CaMKII inhibition., Little is known about how cardiac metabolism remodels following cardiac injury. Here, the authors show that mitochondrial CaMKII plays an important role in remodeling cardiac metabolism after injury and that replacement of mitochondrial creatine kinase improves energetics and protects against adverse remodeling.
- Published
- 2020